May 28 (Reuters) - Merck & Co ( MRK ) is nearing a $1.3
billion cash deal to buy ophthalmology biotechnology company
Eyebiotech in an agreement that could see an additional $1.7
billion in milestone payments, the Wall Street Journal reported
on Tuesday.
(Reporting by Kanjyik Ghosh; Editing by Subhranshu Sahu)